Protagonist Therapeutics Inc buy Citigroup Inc.
Start price
10.11.25
/
50%
€74.00
Target price
10.11.26
€84.79
Performance (%)
-6.76%
Price
13.02.26
€69.00
Summary
This prediction is currently active. With a performance of -6.76%, the BUY prediction for Protagonist Therapeutics Inc by Citigroup_Inc_ is down slightly. This prediction currently runs until 10.11.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -2.817% | -2.817% |
| iShares Core DAX® | 0.463% | -1.530% |
| iShares Nasdaq 100 | -1.792% | -5.385% |
| iShares Nikkei 225® | 5.124% | 8.053% |
| iShares S&P 500 | -1.760% | -3.821% |
Comments by Citigroup_Inc_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (NASDAQ:PTGX) had its price target raised by analysts at Citigroup Inc. from $96.00 to $98.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€43.60
07.08.25
07.08.25
-
07.08.26
07.08.26
58.26%
13.02.26
13.02.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€46.40
17.06.25
17.06.25
€62.32
17.06.26
17.06.26
48.71%
13.02.26
13.02.26